Cytiva completed a KUBio installation for Lonza in Guangzhou Biopark, China. The 17,000-square-meter site includes 6,500 square meters of lab space and one KUBio modular facility, and will focus on antibody development services and manufacturing, including for mAbs and other complex proteins. Source: Genetic Engineering News 14/1/21